跳至主要内容
临床试验/EUCTR2006-000837-36-SE
EUCTR2006-000837-36-SE进行中(未招募)不适用

Effect of Naltrexone on cue-induced craving for Amphetamine in amphetamine dependent individuals

Beroendecentrum Stockholm0 个研究点开始时间: 2006年4月10日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Male

入选标准

  • 1) Men between the ages 20-45 years
  • 2) Fulfils DSM IV diagnosis for amphetamine dependence
  • 3) Consumed amphetamine for minimum of 12 times in the 12 weeks
  • 4) Drug free 2-7 days
  • 5) Abstinent from nicotine and caffeine during the testing day
  • 6) Permanent home address in Stockholm
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1) Fulfils DSM IV diagnosis of any other substance dependence disorder (except nicotine)
  • 2) Fulfils DSM IV diagnosis of any major psychological or psychiatric illness.
  • 3) Traces of cannabis, opiates, cocaine, central amines or benzodiazepines in the urine at the day of testing and between the 2 testing days
  • 4) Traces of alcohol as measured by breathalyser on the days of testing and between the 2 testing days
  • 5) Presence of any serious somatic disorder (example, hypertension, arteriosclerosis, cirrhosis of the liver and hyperthyroidism)
  • 6) Liver enzyme levels (for e.g., AST, ALT, GT) more than 3 times the normal levels
  • 7) Regular use of medication that may confound the effects of the medication (e.g., pain killers, anti-depressants, psychoactive medication)
  • 8) Renal insufficiency
  • 9) Any previous experience with naltrexone
  • 10) Known hypersensitivity to naltrexone
  • 11) Participation as research subjects in clinical trial in the last 6 months.

研究者

发起方
Beroendecentrum Stockholm

相似试验